Literature DB >> 27536587

Clinical Characteristics of Methicillin-resistant Staphylococcus aureus Infection for Chronic Periprosthetic Hip and Knee Infection.

Dong Jin Ryu1, Joon Soon Kang1, Kyoung Ho Moon1, Myung Ku Kim1, Dae Gyu Kwon1.   

Abstract

PURPOSE: Deep infection after hip and knee arthroplasty is a serious complication and is difficult to treat due to its toxicity. The aims of our study were to find out the differences of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) infection after hip and knee arthroplasty focusing on clinical course and laboratory findings.
MATERIALS AND METHODS: We retrospectively reviewed 61 staphylococcal infection cases after hip and knee arthroplasty (MSSA in 25 patients, MRSA in 36 patients). Vital signs, laboratory tests, microbiology and clinical courses were analyzed. The average follow-up period was 3.8 years (range, 2 to 10.1 years).
RESULTS: At initial visit, MRSA group showed significant higher erythrocyte sedimentation rate, C-reactive protein (CRP) and neutrophil percentage. The average duration for the normalization of CRP was longer in MRSA group (MRSA: 36.7±25.1 days, MSSA: 24.7±13.6 days; P=0.008). The mean interval between staging operation was longer in MRSA group (MRSA: mean 8.7 weeks [range, 6.4 to 21.4 weeks], MSSA: mean 6.8 weeks [range, 6 to 13.1 weeks]; P=0.012). MRSA group (13.9%) revealed higher recurrence rate than MSSA group (4%). Two patients (5.6%) from MRSA group expired by sepsis. One limb amputation (2.7%) was carried out in MRSA group.
CONCLUSION: MRSA infection after arthroplasty showed more toxic serologic parameter and poorer prognosis. Aggressive treatment should be considered for MRSA infection following arthroplasty.

Entities:  

Keywords:  Antibiotic resistance; Arthroplasty; Infection; Methicillin-resistant Staphylococcus aureus; Vancomycin

Year:  2014        PMID: 27536587      PMCID: PMC4971399          DOI: 10.5371/hp.2014.26.4.235

Source DB:  PubMed          Journal:  Hip Pelvis        ISSN: 2287-3260


  36 in total

1.  New definition for periprosthetic joint infection.

Authors: 
Journal:  J Arthroplasty       Date:  2011-12       Impact factor: 4.757

2.  Periprosthetic joint infection: the economic impact of methicillin-resistant infections.

Authors:  Javad Parvizi; Ian M Pawasarat; Khalid A Azzam; Ashish Joshi; Erik N Hansen; Kevin J Bozic
Journal:  J Arthroplasty       Date:  2010-05-31       Impact factor: 4.757

3.  Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties.

Authors:  M J Spangehl; B A Masri; J X O'Connell; C P Duncan
Journal:  J Bone Joint Surg Am       Date:  1999-05       Impact factor: 5.284

4.  A two-stage retention débridement protocol for acute periprosthetic joint infections.

Authors:  Chris S Estes; Chris P Beauchamp; Henry D Clarke; Mark J Spangehl
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

5.  Infection after total knee arthroplasty.

Authors:  A W Blom; J Brown; A H Taylor; G Pattison; S Whitehouse; G C Bannister
Journal:  J Bone Joint Surg Br       Date:  2004-07

6.  Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile.

Authors:  Benjamin T Bjerke-Kroll; Alexander B Christ; Alexander S McLawhorn; Peter K Sculco; Kethy M Jules-Elysée; Thomas P Sculco
Journal:  J Arthroplasty       Date:  2013-10-04       Impact factor: 4.757

7.  Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus.

Authors:  John J Hawkshead; Nimesh B Patel; Russell W Steele; Stephen D Heinrich
Journal:  J Pediatr Orthop       Date:  2009 Jan-Feb       Impact factor: 2.324

8.  The microbiology of the infected knee arthroplasty.

Authors:  R S J Nickinson; T N Board; A K Gambhir; M L Porter; P R Kay
Journal:  Int Orthop       Date:  2009-05-21       Impact factor: 3.075

Review 9.  Prophylactic antibiotics in hip and knee arthroplasty.

Authors:  John Meehan; Amir A Jamali; Hien Nguyen
Journal:  J Bone Joint Surg Am       Date:  2009-10       Impact factor: 5.284

Review 10.  Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening.

Authors:  N Goyal; A Miller; M Tripathi; J Parvizi
Journal:  Bone Joint J       Date:  2013-01       Impact factor: 5.082

View more
  3 in total

1.  Does Change in ESR and CRP Guide the Timing of Two-stage Arthroplasty Reimplantation?

Authors:  Jeffrey B Stambough; Brian M Curtin; Susan M Odum; Michael B Cross; J Ryan Martin; Thomas K Fehring
Journal:  Clin Orthop Relat Res       Date:  2019-02       Impact factor: 4.176

2.  Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections.

Authors:  Bingyun Li; Thomas J Webster
Journal:  J Orthop Res       Date:  2017-08-11       Impact factor: 3.494

3.  The Results of Two-stage Revision for Methicillin-resistant Periprosthetic Joint Infection (PJI) of the Hip.

Authors:  A Santoso; T R Yoon; K S Park; I B Anwar; P Utomo; B Soetjahjo; T Sibarani
Journal:  Malays Orthop J       Date:  2020-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.